Zhejiang Drug Rehabilitation Administration
Hangzhou, Zhejiang, 310008, China
NCT Number: NCT04105621
This is a prospective cohort study of drug addicts confined in Zhejiang rehabilitation centers. The primary aim of this study is to investigate the association between diet and health status among drug addicts. The second aim is to characterize the continuous blood glucose response to dietary intakes over 2 weeks. The third aim is to describe the dynamic changes of gut microbiota at three time points in drug addicts during compulsory detoxification and to evaluate the association between gut microbiota, diet and addiction severity.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Hangzhou, Zhejiang, 310008, China
Over recent decades, there is a growing trend of drug addiction in China that poses great public health challenges. Drug abuse can lead to many health related problems such as malnutrition and mental disorders along with reduced quality of life. Dietary intervention plays a pivotal role in disease prevention and drug rehabilitation for drug addicts, but the associations between dietary intake and health related outcomes among drug addicts remain unclear.
In addition, the relationship between the human gut microbiota and its response to addictive drugs as a newly arisen subject is given wide attention in recent years. However, the underlying mechanism requires further investigation. The dynamic changes of gut microbiota among drug addicts during compulsory drug rehabilitation period are in vague.
Under the same diet exposure, different drug addicts may have different blood glucose responses as well as gut microbiota profiles. Therefore, in order to examine the association between diet, gut microbiota and drug addiction, our study design will include three components: (1) the measurement of dietary intake using FFQ while the menu offered by drug rehabilitation center and food diary; (2) the measurements of blood glucose over 2 weeks using continuous glucose monitors; and (3) the measurements of gut microbiota at three time points using 16s rRNA sequencing techniques.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Two weeks after enrollment
Glucose levels were measured using continuous glucose monitoring over 2 week
Time frame: One year after enrollment; includes three sampling time points: baseline, 6 months after enrollment and 12 months after enrollment.
Fecal microbiota was analyzed using16S rRNA gene sequencing technique
Time frame: Baseline; 6 months after enrollment; 12 months after enrollment
This was evaluated by Obsessive Compulsive Drug Use Scale (OCDUS). This scale had 13 items, each with a 5-point Likert-response (1, 2, 3, 4 and 5). Items 6 and 13 were reverse-scored. The total score ranges from 13 to 65 and a higher value represent a higher intensity of drug craving.
Time frame: Baseline; 6 months after enrollment; 12 months after enrollment
BMI in kg/m^2
Time frame: Baseline; 6 months after enrollment; 12 months after enrollment
Nutritional status was measured by mini nutritional assessment (MNA) screening test.
Time frame: Baseline; 6 months after enrollment; 12 months after enrollment
This was evaluated by Beck Depression Inventory-II (BDI-II). Scores in every item of the BDI-II were between 0 and 3. The total score ranges from 0 to 63.
Time frame: Baseline; 6 months after enrollment; 12 months after enrollment
This was evaluated by Hamilton Anxiety Scale (HAMA). Scores in every item of the HAMA were between 0 and 4. The total score ranges from 0 to 56.
Time frame: Baseline; 6 months after enrollment; 12 months after enrollment
Body composition (fat mass, lean mass in kg ) are assessed by bioelectrical impedance analysis.
Westlake University
Other
Acronym: WePN-DA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03918850
Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Jacksonville, Florida, United States
View Trial DetailsNCT03911739
Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Jacksonville, Florida, United States
View Trial DetailsNCT03911466
Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Jacksonville, Florida, United States
View Trial DetailsNCT06262347
Chemically-Induced Disorders, Drug Abuse
Jacksonville, Florida, United States
View Trial Details